Is elevated soluble Interleukin 2 (IL2)/CD25 specific for Hemophagocytic Lymphohistiocytosis (HLH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Specificity of Elevated Soluble IL2/CD25 for HLH

Elevated soluble IL-2 receptor (sCD25) is a good diagnostic marker for HLH but is not specific to this condition alone, as it can be elevated in various inflammatory and malignant conditions. 1

Diagnostic Value of sCD25 in HLH

Soluble IL-2 receptor (sCD25) is one of the eight diagnostic criteria in the HLH-2004 guidelines, with levels ≥ 2400 U/mL supporting the diagnosis of HLH. Recent evidence suggests that sCD25 is a valuable diagnostic test for adult HLH with:

  • Area under the curve of 0.90 (95% CI, 0.83-0.97) 1
  • Superior diagnostic performance compared to ferritin, which has an area under the curve of 0.78 (95% CI, 0.67-0.88) 1

Limitations of sCD25 as a Specific Marker for HLH

Despite its diagnostic value, sCD25 is not specific to HLH alone:

  • sCD25 can be elevated in other conditions characterized by T-cell activation and inflammation 2
  • Elevated levels may be seen in:
    • Malignancies (particularly lymphomas and leukemias)
    • Severe infections
    • Autoimmune disorders
    • Post-transplant states
    • Other inflammatory conditions 3

Role in HLH Pathophysiology

The elevation of sCD25 in HLH has pathophysiological significance:

  • It reflects excessive CD8+ T-cell activation, a hallmark of HLH 3
  • Secretion of soluble CD25 by activated CD8+ T-cells can compete with regulatory T-cells for IL-2, contributing to immune dysregulation 3
  • This competition for IL-2 may create a feed-forward inflammatory loop that perpetuates HLH 3

Clinical Application of sCD25 Testing

When interpreting sCD25 levels:

  1. Consider sCD25 as part of the complete HLH-2004 diagnostic criteria (requiring 5 of 8 criteria) 1, 2
  2. Remember that a single elevated marker is insufficient for diagnosis
  3. Integrate with other clinical and laboratory findings:
    • Fever
    • Splenomegaly
    • Cytopenias
    • Hypertriglyceridemia and/or hypofibrinogenemia
    • Hemophagocytosis in bone marrow/spleen/lymph nodes
    • Low/absent NK cell activity
    • Ferritin ≥ 500 mg/L 1

Comparison with Other HLH Markers

While sCD25 is valuable, it should be compared with other markers:

  • Ferritin: While levels >10,000 μg/L are >90% sensitive and specific for HLH in children, hyperferritinemia is less specific in adults 1, 4
  • A retrospective analysis found marked hyperferritinemia (>50,000 μg/L) in adults with various conditions including renal failure, hepatocellular injury, infections, and hematologic malignancies 4

Clinical Pearls and Pitfalls

  • Don't rely solely on sCD25 for HLH diagnosis; consider the complete clinical picture
  • sCD25 may be mildly elevated in some conditions but markedly elevated in HLH
  • Serial measurements of sCD25 may help monitor disease activity and response to treatment 5
  • Consider testing sCD25 when other features of HLH are present, even if the full diagnostic criteria are not yet met 1
  • In transplant recipients, elevated sCD25 should raise suspicion for HLH, especially in the context of infections 6

In summary, while elevated sCD25 is a valuable diagnostic marker for HLH with good sensitivity, it lacks specificity as a standalone test and must be interpreted within the complete clinical and laboratory context of the patient.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.